FMC Corporation (FMC) Stock Price & Analysis
FMC Corporation (FMC) closed at USD 5.02 on Thursday, October 22, 2026, down 0.20% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 5.03; the Oct 22, 2026 session ranged USD 4.8–5.15 on volume of 7,385,233 shares. Market capitalization is $780.84M, with a 52-week range of USD 4.8–30.95 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/FMC.md
Key facts (FMC)
- Last four reported quarters (through Jun 30, 2026): revenue $3.25B, net income -$2.76B (-84.8% margin), free cash flow $163M (SEC filings).
- 1 of 80 tracked superinvestors hold FMC (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (17 analysts), mean target USD 8.71 (range 4–18).
- Total return with dividends: 1Y -83.0% vs S&P 500 +14.9%; 5Y -93.6% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.08, revenue estimate $317M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (FMC)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.05B | $5.80B | $4.49B | $4.25B | $3.47B | $3.25B |
| Gross profit | $2.16B | $2.33B | $1.83B | $1.65B | $1.28B | — |
| Operating income | $1.03B | $1.14B | $556M | $507M | -$1.63B | -$2.01B |
| Net income | $740M | $737M | $1.32B | $341M | -$2.24B | -$2.76B |
| EPS (diluted) | $5.73 | $5.81 | $10.53 | $2.72 | -$17.88 | — |
| Free cash flow | $799M | $518M | -$434M | $669M | -$103M | $163M |
| Gross margin | 42.8% | 40.1% | 40.8% | 38.8% | 37.0% | — |
| Operating margin | 20.5% | 19.7% | 12.4% | 11.9% | -47.0% | -61.9% |
| Net margin | 14.7% | 12.7% | 29.5% | 8.0% | -64.6% | -84.8% |
| Revenue growth | +8.7% | +15.0% | -22.7% | -5.4% | -18.3% | — |
| Cash + short-term investments | $517M | $572M | $302M | $357M | $585M | — |
| Total debt | $2.82B | $2.82B | $3.12B | $3.10B | $3.36B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (FMC)
P/S 0.2x · EV/Sales 1.3x · P/FCF 4.8x · P/B 0.5x · FCF yield 20.93% · Earnings yield -353.21% · Dividend yield (paid, TTM) 21.26% · Net debt $3.49B · EV $4.27B
P/E at fiscal year-ends: Dec 2024 17.9x, Dec 2023 6.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (FMC)
1 of 80 tracked investors hold FMC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Tweedy Browne | 0.04% | $505K | Added +42.3% |
Analysts (FMC)
Consensus Hold (mean 3.00 on a 1–5 scale), 17 analysts; mean target USD 8.71 (low 4, high 18).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Citigroup | Target lowered | Neutral | $12 → $6 |
| 2026-10-16 | Barclays | Target lowered | Underweight | $9 → $4 |
| 2026-10-16 | BMO Capital | Target lowered | Market Perform | $11 → $7.5 |
| 2026-10-16 | Jefferies | Downgrade | Buy → Hold | $14 → $5 |
| 2026-10-15 | RBC Capital | Target lowered | Sector Perform | $11 → $9 |
| 2026-10-13 | Mizuho | Target lowered | Outperform | $15 → $12 |
| 2026-10-05 | UBS | Target lowered | Neutral | $12 → $10 |
| 2026-09-11 | Keybanc | Initiated | Overweight | $16 |
| 2026-08-03 | RBC Capital | Target lowered | Sector Perform | $12 → $11 |
| 2026-07-31 | Citigroup | Target lowered | Neutral | $14 → $12 |
| 2026-07-31 | JP Morgan | Target lowered | Neutral | $16 → $12 |
| 2026-07-31 | Morgan Stanley | Target lowered | Equal-Weight | $15.5 → $12 |
Total return (dividends reinvested) (FMC)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -83.0% | -93.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -83.1% | -42.3% |
| Volatility (annualized) | 94.4% | 57.4% |
| Max drawdown | -83.2% (Oct 2025→Oct 2026) | -95.8% (Apr 2022→Oct 2026) |
FMC analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.08 | $0.63 | -87.9% | $317.0M | 8 |
| Next quarter (ends Dec 2026) | $0.94 | $0.99 | -4.9% | $1.05B | 11 |
| Current fiscal year (ends Dec 2026) | $1.20 | $1.66 | -27.6% | $3.26B | 9 |
| Next fiscal year (ends Dec 2027) | $1.39 | $2.02 | -31.0% | $3.53B | 11 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 5.02 |
|---|---|
| Change | ▼ 0.20% (down) |
| Previous Close | USD 5.03 |
| Open | USD 4.8 |
| Day Range | USD 4.8 – 5.15 |
| 52-Week Range | USD 4.8 – 30.95 |
| Volume | 7,385,233 shares |
| Market Cap | $780.84M |
| Exchange | NYQ |
Technical Analysis (FMC)
Nexqual's technical model rates FMC "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 10.08 (oversold) |
| vs SMA50 | Below (USD 9.77) |
| MACD | -1.37 (negative) |
Analyst Ratings (FMC)
Wall Street analysts rate FMC "Hold" based on 17 analysts, with a mean price target of USD 8.71 (range USD 4–18), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 8.71 |
| High Target | USD 18 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 3 / 12 / 2 |
Earnings (FMC)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.08 |
| Revenue Estimate | $316.99M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.26 vs est 0.22 ▲ beat |
| 2026-03-31 | USD -0.23 vs est -0.38 ▲ beat |
| 2025-12-31 | USD 1.2 vs est 1.2 ▼ miss |
| 2025-09-30 | USD 0.89 vs est 0.85 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (FMC)
| Total Revenue | $3.25B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -17.50% |
| Gross Margin | +31.93% |
| Operating Margin | +11.83% |
| Profit Margin | -84.83% |
| ROE | -88.38% |
| Debt / Equity | 2.65 |
| Current Ratio | 1.99 |
| Total Cash | $476.60M |
| Total Debt | $4.40B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $163.40M (5.0% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (FMC)
Nexqual rates FMC Corporation's overall financial health "Weak" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Critical — Revenue -18% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 32%, operating 12% (last 12 months) |
| Balance Sheet | Weak — $477M cash and investments vs $3.96B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $163M (last 4 quarters to Jun 2026, SEC), 5% margin |
| Efficiency | Critical — ROE -88%, ROA 0.6% |
Ownership (FMC)
| Insider Ownership | +20.75% |
|---|---|
| Institutional Ownership | +84.15% |
| Shares Outstanding | 155.55M |
| Float | 92.73M |
| Short % of Float | +23.22% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (FMC)
FMC Corporation is led by Pierre R. Brondeau, President, CEO & Non-Executive Chairman of the Board, per Nexqual as of October 23, 2026 at 09:25 UTC.
| President, CEO & Non-Executive Chairman of the Board | Pierre R. Brondeau |
|---|---|
| Executive VP & CFO | Andrew D. Sandifer |
| Executive VP & CTO | Vsevolod Rostovtsev |
| Executive Vice President & President, FMC Eurasia | Sebastia Pons |
| Director & Head of Business Sustainability and Strategic Initiatives in Asia Pacific (APAC) | Shahid Saleem |
Major Backers & Investors (FMC)
Notable institutional backers of FMC Corporation include AQR Capital Management, LLC, American Century Companies Inc, Shaw D.E. & Co., Inc., according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AQR Capital Management, LLC | 6.41% |
| American Century Companies Inc | 4.04% |
| Shaw D.E. & Co., Inc. | 3.92% |
| Two Sigma Investments, LP | 2.26% |
| UBS Group AG | 2.01% |
| Fidelity | 1.12% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 17.2% |
| Vanguard Group | 10.76% |
| State Street | 5.2% |
| Geode Capital | 2.62% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPI | Intrepid Potash, Inc | USD 30.77 | ▼ 1.38% |
| SMG | Scotts Miracle-Gro Company (The | USD 59.15 | ▲ 5.76% |
| MOS | Mosaic Company (The) | USD 17.27 | ▼ 2.32% |
| CTVA | Corteva, Inc. | USD 12.86 | ▲ 1.1% |
| CF | CF Industries Holdings, Inc. | USD 118.56 | ▲ 1.94% |
| NTR | Nutrien Ltd. | USD 69.09 | ▲ 1.42% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt